Rapamycin use in cats with subclinical hypertrophic cardiomyopathy
oin us for this exciting discussion as we welcome Dr. Joshua Stern, DVM, PhD, DACVIM (Cardiology) to discuss results of the recently completed RAPACAT trial, evaluating the effects of delayed release rapamycin on left ventricular wall thickness in cats with hypertrophic cardiomyopathy (HCM).
Read more